CNS & Neurological Disorders - Drug Targets
Title:Commentary: Endophenotypes as Disease Modifiers: Decoding the Biology of Alzheimer’s by Genome-wide Association Studies
Volume: 17 Issue: 1
Author(s): A.R. Neelakandan and G.K. Rajanikant*
Affiliation:
- School of Biotechnology, National Institute of Technology Calicut, Calicut-673601,India
Export Options
About this article
Cite this article as:
Neelakandan A.R. and Rajanikant G.K.*, Commentary: Endophenotypes as Disease Modifiers: Decoding the Biology of Alzheimer’s by Genome-wide Association Studies, CNS & Neurological Disorders - Drug Targets 2018; 17 (1) . https://dx.doi.org/10.2174/1871527317666180213143832
DOI https://dx.doi.org/10.2174/1871527317666180213143832 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Morphine as a Potential Oxidative Stress-Causing Agent
Mini-Reviews in Organic Chemistry Investigation of the Biological Activities of Different Extracts from Dipsacus laciniatus Aerial Parts
The Natural Products Journal Marijuana Use in Young Adults: What Do We Know?
Current Psychopharmacology miR-135a Suppresses Calcification in Senescent VSMCs by Regulating KLF4/STAT3 Pathway
Current Vascular Pharmacology Measuring Alzheimer Disease Progression with Transition Probabilities: Estimates from NACC-UDS
Current Alzheimer Research Hippocampal Morphology and Autobiographic Memory in Mild Cognitive Impairment and Alzheimer’s Disease
Current Alzheimer Research Cellular and Molecular Networks in Chronic Myeloid Leukemia: The Leukemic Stem, Progenitor and Stromal Cell Interplay
Current Drug Targets Signaling Through Rho GTPase Pathway as Viable Drug Target
Current Medicinal Chemistry WISP1 (CCN4) Autoregulates its Expression and Nuclear Trafficking of β-Catenin during Oxidant Stress with Limited Effects upon Neuronal Autophagy
Current Neurovascular Research Targeting the Neuronal Activity of Prefrontal Cortex: New Directions for the Therapy of Depression
Current Neuropharmacology Toward a Molecular Understanding of the Interaction of Dual Specificity Phosphatases with Substrates: Insights from Structure-Based Modeling and High Throughput Screening
Current Medicinal Chemistry New Antiepileptic Drugs: Molecular Targets
Central Nervous System Agents in Medicinal Chemistry The Role of 11Beta-Hydroxysteroid Dehydrogenase in Metabolic Disease and Therapeutic Potential of 11Beta-HSD1 Inhibitors
Current Medicinal Chemistry Cell Hierarchy, Metabolic Flexibility and Systems Approaches to Cancer Treatment
Current Pharmaceutical Biotechnology Neurogenesis as a Therapeutic Strategy for Cognitive Aging and Alzheimers Disease
Current Alzheimer Research Herb-drug Interactions Involving Drug Metabolizing Enzymes and Transporters
Current Drug Metabolism Epicardial Adipose Tissue As New Cardio-Metabolic Risk Marker and Potential Therapeutic Target in the Metabolic Syndrome
Current Pharmaceutical Design A Meta-analysis and Systematic Review of Randomised Controlled Trials Comparing Cognitive Behavioural Therapy to Conventional Treatment of Osteoarthritis
Current Rheumatology Reviews Changes in Cognition, Depression and Quality of Life after Carotid Stenosis Treatment
Current Neurovascular Research Hydrophilic Interaction Liquid Chromatography Tandem Mass Spectrometry: An Attractive and Prospective Method for Quantitative Bioanalysis in Drug Metabolism
Current Drug Metabolism